Triasima Portfolio Management Inc. Vertex Pharmaceuticals Inc Transaction History
Triasima Portfolio Management Inc.
- $451 Million
- Q4 2024
A detailed history of Triasima Portfolio Management Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Triasima Portfolio Management Inc. holds 11,660 shares of VRTX stock, worth $5.39 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
11,660
Previous 11,533
1.1%
Holding current value
$5.39 Million
Previous $5.36 Million
12.46%
% of portfolio
1.04%
Previous 1.39%
Shares
13 transactions
Others Institutions Holding VRTX
# of Institutions
1,732Shares Held
227MCall Options Held
1.65MPut Options Held
1.32M-
Capital World Investors Los Angeles, CA28.3MShares$13.1 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.8 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.86 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.47 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.82 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $119B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...